News

Latest Press Releases

BioPorto Initiates Patient Enrollment for US Pediatric Study of The NGAL Test™

First patients enrolled at Cincinnati Children’s Hospital, a leading US center for critical care nephrology

June 23, 2020

BioPorto Submits Pediatric Application to FDA for The NGAL Test™ Under Breakthrough Designation

First test focused on risk assessment of Acute Kidney Injury in pediatric patients

May 15, 2019

BioPorto Appoints New President of BioPorto Diagnostics, Inc.

Company Plans to Bring Novel Kidney Diagnostic to US Market

April 15, 2019